Related references
Note: Only part of the references are listed.Clinicopathologic Significance of Sox2, CD44 and CD44v6 Expression in Intrahepatic Cholangiocarcinoma
Mi Jin Gu et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
Petra M. Bareiss et al.
CANCER RESEARCH (2013)
Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract
Hiroshi Kitamura et al.
MODERN PATHOLOGY (2013)
Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug
Chun Sun et al.
MEDICAL ONCOLOGY (2013)
High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas
Vamsidhar Velcheti et al.
PLOS ONE (2013)
Morphologic and Clinicopathologic Features of Lung Squamous Cell Carcinomas Expressing Sox2
Luka Brcic et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
The Tyrosine Kinase c-Met Contributes to the Pro-tumorigenic Function of the p38 Kinase in Human Bile Duct Cholangiocarcinoma Cells
Rongyang Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric Carcinoma
Junko Matsuoka et al.
JOURNAL OF SURGICAL RESEARCH (2012)
Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer
Sabine Stolzenburg et al.
NUCLEIC ACIDS RESEARCH (2012)
Sox2 expression in breast tumours and activation in breast cancer stem cells
O. Leis et al.
ONCOGENE (2012)
High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis
Yoshitaka Michifuri et al.
PATHOLOGY INTERNATIONAL (2012)
Silencing SOX2 Induced Mesenchymal-Epithelial Transition and Its Expression Predicts Liver and Lymph Node Metastasis of CRC Patients
Xu Han et al.
PLOS ONE (2012)
Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma
Claudia Lengerke et al.
BMC CANCER (2011)
SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer
Jens Neumann et al.
BMC CANCER (2011)
Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy
Pinzhu Huang et al.
CLINICAL BIOCHEMISTRY (2011)
Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas
Yuji Guo et al.
HISTOPATHOLOGY (2011)
SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer
Theresia Wilbertz et al.
MODERN PATHOLOGY (2011)
Expression of Sox2 in human cervical carcinogenesis
Jing Ji et al.
HUMAN PATHOLOGY (2010)
SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis
T. Otsubo et al.
BRITISH JOURNAL OF CANCER (2008)
Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells
Helen Fong et al.
STEM CELLS (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells
Shinji Masui et al.
NATURE CELL BIOLOGY (2007)
Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer
Socorro M. Rodriguez-Pinilla et al.
MODERN PATHOLOGY (2007)
Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression
Hania Wehbe et al.
CANCER RESEARCH (2006)
Cholangiocarcinoma
T Patel
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt
C Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents
JLS Cheng et al.
GASTROINTESTINAL ENDOSCOPY (2002)
Share Paper
